États-Unis · Plateformes & données · TipRanks

Cullinan Shares Updated CLN-049 Phase 1 AML/MDS Data

Publié par TipRanks · États-Unis il y a 10 h

Cullinan Management ( ($CGEM) ) has provided an announcement. On November 4, 2026, Cullinan shared updated Phase 1 dose-escalation data for CLN-049 in 87 patients ...

Lire l'article complet sur TipRanks Connectez-vous pour sauvegarder

MarketNews présente le titre et le résumé publiés par le média. L'article complet se lit sur le site de l'éditeur. (www.tipranks.com)

Cullinan Shares Updated CLN-049 Phase 1 AML/MDS Data

À lire aussi

Moderna says Ebola vaccine picked for Phase 2/3 trial in Africa

Why Palantir Technologies Stock Dropped Today

Fairfax Financial (OTCMKTS:FRFHF) Hits New 1-Year High After Strong Earnings

Medicare prescription drug costs will jump 50% in 2027. Doing nothing could cost you.

10-year Treasury yield is little changed as traders mull over Democrats' midterm victories

Toncoin (TON) Price Prediction 2025, 2026, 2027-2030

Cullinan Shares Updated CLN-049 Phase 1 AML/MDS Data

Partager

À lire aussi

Moderna says Ebola vaccine picked for Phase 2/3 trial in Africa

Why Palantir Technologies Stock Dropped Today

Fairfax Financial (OTCMKTS:FRFHF) Hits New 1-Year High After Strong Earnings

Medicare prescription drug costs will jump 50% in 2027. Doing nothing could cost you.

10-year Treasury yield is little changed as traders mull over Democrats' midterm victories

Toncoin (TON) Price Prediction 2025, 2026, 2027-2030